Shortage of Nucala (mepolizumab) Pre-Filled Pen (EU/1/15/1043/003, EU/1/15/1043/004)
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Nucala
|
| Active substance |
Mepolizumab
|
| Therapeutic area (MeSH) |
Asthma
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
R03DX09
|
| Dissemination date |
23/01/2021
|